RUDOLF BUCCI: Open Payments
NPI 1003954140 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 68 payments from 17 companies in 2025. Trend: 2023 $1,102 · 2024 $1,219 · 2025 $1,280
Food & beverage: $1,235Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $276 |
| Lilly USA, LLC | 13 | $188 |
| Insulet Corporation | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Ascendis Pharma Endocrinology Inc | 3 | $84 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Abbott Laboratories | 3 | $54 |
| Exact Sciences Corporation | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Merck Sharp & Dohme LLC | 2 | $40 |
Products named: Omnipod, JARDIANCE, Yorvipath, TRELEGY ELLIPTA, BREZTRI, FREESTYLE LIBRE 3, Ozempic, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
